What is Verrutopic AS?
Verrutopic AS topical is used to treat many skin disorders, such as acne, dandruff, psoriasis, seborrheic dermatitis of the skin and scalp, calluses, corns, common warts, and plantar warts, depending on the dosage form and strength of the preparation.
Verrutopic AS is available without a prescription. Some of these preparations are available only with your doctor's prescription.
Verrutopic AS indications
For Dermatologic Use: Verrutopic AS 6% is a topical aid in the removal of excessive keratin in hyperkeratotic skin disorders including verrucae, and the various ichthyoses (vulgaris, sex-linked and lamellar), keratosis palmaris and plantaris keratosis pilaris, pityriasis rubra pilaris, and psoriasis (including body, scalp, palms and soles).
For Podiatric Use: Verrutopic AS 6% is a topical aid in the removal of excessive keratin on dorsal and plantar hyperkeratotic lesions.
Topical preparations of 6% Verrutopic AS have been reported to be useful adjunctive therapy for verrucae plantares.
How should I use Verrutopic AS?
Use Verrutopic AS shampoo as directed by your doctor. Check the label on the medicine for exact dosing instructions.
- To use shampoo as a scalp treatment: Use before bathing. Do not wet hair. Apply Verrutopic AS shampoo with the applicator directly to affected areas of the scalp. Leave on for 5 minutes, gradually increasing the treatment time up to 1 hour, or as directed by your doctor. After treatment, rinse thoroughly with water. Wash your hands after each use. You may use a non-medicated shampoo after using Verrutopic AS shampoo, if desired.
- To use shampoo as a medicated shampoo: Wet hair, apply Verrutopic AS shampoo with the applicator directly to scalp, and massage vigorously for several minutes. Rinse thoroughly. Be sure to wash your hands after each use. Use Verrutopic AS shampoo daily until the condition clears, or as directed by your doctor.
- To use the gel on the skin: Moisten the affected area and keep damp for at least 5 minutes before you apply Verrutopic AS shampoo. Apply Verrutopic AS shampoo to the affected area as directed. Cover the treated area at night unless your doctor tells you otherwise. If applying to an area that cannot be covered, check with your doctor for instructions. Wash Verrutopic AS shampoo off in the morning.
- To use gel as a scalp treatment: Apply Verrutopic AS shampoo with the applicator directly to affected areas of the scalp. Avoid contact with unaffected hair or skin. Leave the medicine on for 10 to 20 minutes initially, gradually increasing the treatment time to one hour, or as directed by your doctor. The gel may be washed off using the medicated shampoo or warm water in a bath or shower.
- Wash hands immediately after you use Verrutopic AS shampoo, unless your hands are part of the treated area.
- If you miss a dose of Verrutopic AS shampoo, use it as soon as possible. If it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not use 2 doses at once.
Ask your health care provider any questions you may have about how to use Verrutopic AS shampoo.
Uses of Verrutopic AS in details
This medication is used on the skin to treat common skin and foot (plantar) warts. Verrutopic AS helps cause the wart to gradually peel off. This medication is also used to help remove corns and calluses. This product should not be used on the face or on moles, birthmarks, warts with hair growing from them, or genital/anal warts.
Verrutopic AS is a keratolytic. It belongs to the same class of drugs as aspirin (salicylates). It works by increasing the amount of moisture in the skin and dissolving the substance that causes the skin cells to stick together. This makes it easier to shed the skin cells. Warts are caused by a virus. Verrutopic AS does not affect the virus.
How to use Verrutopic AS topical
Follow all directions on the product package. If you are uncertain about any of the information, consult your doctor or pharmacist.
This medication is for use on the skin only. To avoid irritation, do not let this medication come into contact with your eyes, nose, mouth, groin, or any broken skin. If you do get the medication in those areas, flush the area with cool water for 15 minutes. Wash hands after use.
First, soak the corn, callus, or wart in warm water for about 5 minutes to soften the treatment area. Dry thoroughly. Your doctor may direct you to use a pumice stone, callus file, or emery board to carefully remove the top dead layers of skin after soaking and before applying the medication. This dead skin removal is only to help the medication work better. Do not try to rub the wart or callus off.
If you are using a liquid/gel, apply a few drops or a thin coat of the medication to cover the entire wart, callus, or corn using the applicator if provided. Be careful to apply it only to the affected area and not the surrounding skin. Let dry for 5 minutes. Depending on the brand used, you may need to apply the medication twice with each treatment. Check your product package and follow the directions carefully. You may cover the area loosely with a bandage. Repeat this procedure 1 to 2 times daily for up to 2 weeks for corns and calluses and 12 weeks for warts or as directed by your doctor.
If you are using a medicated pad or bandage, you may need to cut the pad so that it covers the treatment area completely but does not touch the surrounding skin. Peel off the protective covering and place the patch/bandage over the area. Leave in place according to package directions. Remove and place a new patch/bandage as directed (usually every 8 to 48 hours depending on brand). Repeat this procedure for up to 2 weeks for corns and calluses and 12 weeks for warts.
Dosage is based on your medical condition, product type/brand, and response to treatment. Do not use large amounts, apply this medication more often, or use it for a longer period than directed. Your condition will not clear faster, but the chance for side effects may be increased.
Use this medication regularly to get the most benefit from it. To help you remember, use it at the same time each day.
If your condition persists or worsens, or if you think you may have a serious medical problem, seek immediate medical attention.
Verrutopic AS description
Each mL contains anthraquinone glycosides 50 mg, Verrutopic AS 10 mg and alcohol 60%.
Verrutopic AS dosage
Verrutopic AS Dosage
Generic name: Verrutopic AS 275mg in 1mL
Dosage form: topical solution
The information at Drugs.com is not a substitute for medical advice. Always consult your doctor or pharmacist.
Rx only
FOR TOPICAL USE ONLY.
NOT FOR OPHTHALMIC, ORAL OR INTRAVAGINAL USE.
DESCRIPTION
Verrutopic AS is a topical preparation containing 27.5% Verrutopic AS in a proprietary film-forming vehicle that comprises isopropyl alcohol, butyl acetate, polyvinyl butyral, isopropyl metacresol, trimethyl pentanyl diisobutyrate, phenic acid and acrylates copolymer. The pharmacologic activity of Verrutopic AS is generally attributed to the keratolytic activity of Verrutopic AS which is incorporated into a polyacrylic, film-forming virucidal vehicle designed to cover the wart without the need for a bandage. The structural formula of Verrutopic AS is:
CLINICAL PHARMACOLOGY
Although the exact mode of action for Verrutopic AS in the treatment of warts is unknown, its activity appears to be associated with its keratolytic action, which results in mechanical removal of epidermal cells infected with wart viruses.
The virucidal complex incorporated into Verrutopic AS’s proprietary vehicle is designed to help reduce risk of reinfection at the wart site, as well as prevent viral contamination of the product under normal usage.
INDICATIONS AND USAGE
Verrutopic AS is indicated for the topical treatment and removal of common warts and plantar warts.
CONTRAINDICATIONS
Patients with diabetes or impaired blood circulation should not use Verrutopic AS. Verrutopic AS also should not be used on moles, birthmarks, and unusual warts with hair growing from them, or warts on the face.
PRECAUTIONS
Verrutopic AS is for external use only. Do not permit Verrutopic AS to contact eyes or mucous membranes. If contact with eyes or mucous membranes occurs, immediately flush with water for 15 minutes. Verrutopic AS should not be allowed to contact normal skin surrounding wart, since localized irritation may occur. Treatment should be discontinued if excessive irritation occurs. Verrutopic AS is flammable. Keep away from fire or flame. Keep bottle tightly capped when not in use.
ADVERSE REACTIONS
A localized irritant reaction may occur if Verrutopic AS is applied to the normal skin surrounding the wart. Any irritation may normally be controlled by temporarily discontinuing use and by applying the medication only to the wart site when treatment is resumed.
DOSAGE AND ADMINISTRATION
Prior to applying Verrutopic AS, soak wart in warm water for five minutes. Remove any loosened tissue by gently rubbing with a brush, wash cloth, or emery board. Dry wart site thoroughly. Using the brush applicator supplied, apply Verrutopic AS twice to entire wart surface, allowing the first application to dry before applying the second. Continue treatment once or twice a day as directed by physician. Be careful not to apply to surrounding skin.
Clinically visible improvement will normally occur during the first or second week of therapy. Maximum resolution may be expected after four to six weeks of Verrutopic AS use.
HOW SUPPLIED
Verrutopic AS is supplied in 10ml amber bottles with a brush applicator (NDC 42783-312-10).
Store at controlled room temperature, 15° to 30°C (59° to 86°F).
Manufactured for:
Elorac, Inc.
Vernon Hills, IL 60061
U.S. Patent Pending
Revised 06/2011
221619
More about Verrutopic AS (Verrutopic AS topical)
- Side Effects
- Dosage Information
- Drug Interactions
- Support Group
- Pricing & Coupons
- 0 Reviews - Add your own review/rating
Consumer resources
- Verrutopic AS
- Verrutopic AS
Topical (Advanced Reading)
- Other brands: Compound W, Dr Scholl's Callus Removers, Duofilm, Wart Remover, More (50) »
Professional resources
- Verrutopic AS (FDA)
- Verrutopic AS (AHFS Monograph)
Related treatment guides
- Warts
Verrutopic AS interactions
Allergies
Tell your doctor if you have ever had any unusual or allergic reaction to Verrutopic AS or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.
Pediatric
Young children may be at increased risk of unwanted effects because of increased absorption of Verrutopic AS through the skin. Also, young children may be more likely to get skin irritation from Verrutopic AS. Verrutopic AS should not be applied to large areas of the body, used for long periods of time, or used under occlusive dressing (air-tight covering, such as kitchen plastic wrap) in infants and children. Verrutopic AS should not be used in children younger than 2 years of age.
Geriatric
Elderly people are more likely to have age-related blood vessel disease. This may increase the chance of problems during treatment with Verrutopic AS.
Breast Feeding
There are no adequate studies in women for determining infant risk when using this medication during breastfeeding. Weigh the potential benefits against the potential risks before taking this medication while breastfeeding.
Verrutopic AS side effects
See also:
What are the possible side effects of Verrutopic AS?
Less common or rare
Skin irritation not present before use of Verrutopic AS (moderate or severe)
Frequency not known
Dryness and peeling of skin
flushing
redness of skin
unusually warm skin
Symptoms of Verrutopic AS poisoning
Confusion
diarrhea
dizziness
fast or deep breathing
headache (severe or continuing)
hearing loss
lightheadedness
nausea
rapid breathing
ringing or buzzing in ears (continuing)
severe drowsiness
stomach pain
vomiting
Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
More common
-Skin irritation not present before use of Verrutopic AS (mild) -stinging
Verrutopic AS contraindications
See also:
What is the most important information I should know about Verrutopic AS?
Less common or rare
Skin irritation not present before use of Verrutopic AS (moderate or severe)
Frequency not known
Dryness and peeling of skin
flushing
redness of skin
unusually warm skin
Symptoms of Verrutopic AS poisoning
Confusion
diarrhea
dizziness
fast or deep breathing
headache (severe or continuing)
hearing loss
lightheadedness
nausea
rapid breathing
ringing or buzzing in ears (continuing)
severe drowsiness
stomach pain
vomiting
Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
More common
-Skin irritation not present before use of Verrutopic AS (mild) -stinging
Active ingredient matches for Verrutopic AS:
Salicylic Acid in Argentina.
List of Verrutopic AS substitutes (brand and generic names) | Sort by popularity |
| Unit description / dosage (Manufacturer) | Price, USD |
| Urgocor (Czech Republic) | |
| Bandage; Medicated; Salicylic Acid 32 mg (Crefar) | |
| Urgocor Coricide | |
| Patch; Topical; Salicylic Acid 32 mg | |
| Ven Hex (Venezuela) | |
| Vericaps (Ireland) | |
| Verruca (Greece, Malta) | |
| Verruca removal (Czech Republic) | |
| Verruca Treatment (United Kingdom) | |
| Verrucid (Germany) | |
| Verrucosal (France) | |
| Verrugon (United Kingdom) | |
| Verrukid Pediatrico (Argentina) | |
| Verrupatch (Spain) | |
| Verruplan (Spain) | |
| Verrutrix (Argentina) | |
| Verruxane (Argentina) | |
| Verucca Removal System (United Kingdom) | |
| Viranol (United States) | |
| Viranol Gel | |
| Gel; Topical; Salicylic Acid | |
| Virasal | |
| Virasal solution 275 mg/mL (Elorac, Inc. (US)) | |
| Virasal Film-Forming Liquid | |
| Virasal Topical | |
| Virtual Clarity | |
| Lotion; Topical; Salicylic Acid 0.5% | |
| Virtual Clarity lotion 0.5 % (Flageoli Limited (Canada)) | |
| Wart-Off (Lithuania, United States) | |
| Wart-Off Maximum Strength | |
| Wart-Off Maximum Strength Topical | |
| Welsalic (India) | |
| Welsalic 2% w/w F-WASH / 60ml (Biochemix (Nirix)) | $ 1.33 |
| WELSALIC Face- wash 2 % w/w x 60ml (Biochemix (Nirix)) | $ 1.33 |
| Whitfield SF | |
| Whitfield SF Salicylic Acid 3% w/w, BenzoicAcid 6% w/w OINT / 50g (Dr Reddy Laboratories Ltd) | $ 0.28 |
| Whitfield SF Skin 50 gm Ointment (Dr Reddy Laboratories Ltd) | $ 0.28 |
| Wurzeltod Huhneraugen und Hornhautpflaster | |
| Patch; Topical; Salicylic Acid 80% | |
| Wurzeltod Warzenpflaster | |
| Patch; Topical; Salicylic Acid 0.8% | |
| Yalta corn salve (South Africa) | |
| Zap-It! Acne Medication Quick Stick | |
| Liquid; Topical; Salicylic Acid 2% | |
| Zap-It! Deep-Cleaning Astringent | |
| Liquid; Topical; Salicylic Acid 0.5% | |
| Zap-It! Facial Wash | |
| Gel; Topical; Salicylic Acid 0.5% | |
| Zap-It! Pore Clarifying Cream | |
| Cream; Topical; Salicylic Acid 2% | |
| Zapzyt | |
| Zapzyt Topical | |
| Zema Lotion (Thailand) | |
| Zema Lotion 15 mL x 12's | $ 4.42 |
| Zino (Greece) | |
See 1277 substitutes for Verrutopic AS | |
References
- PubChem. "salicylic acid". https://pubchem.ncbi.nlm.nih.gov/com... (accessed September 17, 2018).
- DrugBank. "salicylic acid". http://www.drugbank.ca/drugs/DB00936 (accessed September 17, 2018).
- DTP/NCI. "salicylic acid: The NCI Development Therapeutics Program (DTP) provides services and resources to the academic and private-sector research communities worldwide to facilitate the discovery and development of new cancer therapeutic agents.". https://dtp.cancer.gov/dtpstandard/s... (accessed September 17, 2018).
Reviews
The results of a survey conducted on ndrugs.com for Verrutopic AS are given in detail below. The results of the survey conducted are based on the impressions and views of the website users and consumers taking Verrutopic AS. We implore you to kindly base your medical condition or therapeutic choices on the result or test conducted by a physician or licensed medical practitioners.User reports
Consumer reported useful
No survey data has been collected yetConsumer reported price estimates
No survey data has been collected yetConsumer reported time for results
No survey data has been collected yetConsumer reported age
No survey data has been collected yetConsumer reviews
There are no reviews yet. Be the first to write one! |
Information checked by Dr. Sachin Kumar, MD Pharmacology
